Alung technologies, inc.Manufactures the hemolung ras and catheter.The incident occurred in stoke on trent, united kingdom.Through review of the final clinical study adverse event listings, it was reported that a device malfunction occurred during therapy.Throughout patient therapy, there were concerns regarding co2 removal.As per the event, multiple low co2 removal alarms occurred.As no further notification was received regarding this adverse event, no further information is available.There are many factors that can impact level of co2 removal during therapy.This is a known potential complication.No capa was opened because of this event.From the event, clinical support was provided without issue in response to the concerns.Alung technologies, inc.Will continue to monitor any issues as they are reported.This mdr is being filed in response to a retrospective view of all alung technologies, inc.Complaints, which identified that the reporting decision for this complaint was not correct.This mdr is being filed retrospectively to correct the error in the reporting decision.
|